[COVID-19 in the indigenous population: scoping review]

The objective of this article is to map the available evidence about COVID-19 in the indigenous population. Scoping review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension (PRISMA-ScR), guided by the Joanna Briggs Institute. Data sources were MEDLINE/PubMed, Cochrane Library, Embase, Web of Science, SCOPUS, LILACS, ClinicalTrials.gov, WHO ICTRP, British Library, Google Scholar and Preprints, without date or language restrictions. Two independent researchers performed data selection, mapping and synthesis, with the help of EndNote and Rayyan. Initially, 2,224 studies were identified, resulting in a final sample of 47. The countries with the most publications were the USA, Brazil and Mexico, with a concentration in 2021 (42.6%). A higher number of deaths was observed among indigenous men over 60 years of age. The prevalent comorbidities were cardiovascular diseases, diabetes, hypertension and obesity. Incidence and mortality rates were higher among indigenous people compared to other races. COVID-19 continues to be a threat to indigenous health, and it is necessary to intensify vaccination and adopt other preventive measures to avoid outbreaks and mitigate the effects of the disease, given the greater vulnerability of this population.